Introduction
It has been shown that access to unrelated SCT can differ considerably between various ethnic groups. [1] [2] [3] [4] [5] [6] Groupspecific transplantation probabilities may depend on the number of registered stem cell donors of a specific ethnic group, the level of intra-group HLA diversity, genetic distances from other ethnic groups, group-specific donor availability rates, sociocultural and socioeconomic factors. One approach to increase low transplantation probabilities for patients of specific ethnic groups consists of donor recruitment efforts targeted to these groups. The relevance of this issue is emphasized by the fact that the Genetic Diversity Working Group of the World Marrow Donor Association runs a project intended to share knowledge regarding such directed recruitment strategies between different registries. 7 In this work, we develop criteria for the initiation and evaluation of minority donor programs. The criteria have been applied to the situation of donors of Turkish descent in Germany and the corresponding program was run by the DKMS German Bone Marrow Donor Center.
Methods
Definition and elements of minority donor programs Minority donor programs aim for the recruitment and support of stem cell donors of an ethnic group that constitutes a minority in the operating area of a donor center or registry. Such programs should increase the probability for patients from the addressed minority of finding a matching stem cell donor and proceeding to transplantation. Typical elements of minority donor programs are: specific minority donor drives for patients of the targeted population; tailored marketing and information material, for example material in the language of the ethnic group under consideration; cooperation with media preferably used by individuals of the minority population; and native speaker support for potential minority donors at recruitment and through the various process steps until donation.
Criteria for the initiation of minority donor programs Three criteria for the initiation of a minority donor program can be derived from the above-mentioned goal of increasing the probability of patients from a specific minority finding a matching stem cell donor and advancing to transplantation:
First, there should be a 'critical mass' of potential donors of the ethnic group analyzed in the recruiting area to justify the effort of a program with the above-mentioned features. Obviously, if there are general reasons such as religious beliefs that exclude the considered group from stem cell donation, this should also be taken into account.
Second, the probabilities of patients in the ethnic group analyzed finding matched unrelated donors have to be assessed. Low probabilities that can be improved through further recruitment from the respective population indicate a need for a specific program. Such evidence is principally yielded from the results of real donor searches but might be difficult to obtain or interpret. In such cases, it seems reasonable to assume low probabilities of finding matching donors when two conditions are fulfilled: a low number of registered and available donors from the ethnic group being addressed, and sufficiently large differences between HLA phenotype distributions of this group and other ethnic groups with large donor pools.
Third, many individuals of the ethnic group analyzed should have general access to unrelated allo-SCT, that is, they should have the chance to advance to transplantation if a matched unrelated donor is available. Otherwise, the recruitment of additional stem cell donors would not be beneficial for these patients. The preferred stem cell sources in countries with large populations of the analyzed ethnic group should also be considered. The collection of cord blood units (CBUs), for example, could improve low chances of minority patients finding sufficiently matched stem cell donors very efficiently owing to less strict HLA matching requirements for cord blood. 8 If there is, however, no regular use of CBUs in countries with large populations of the analyzed ethnic group, a minority program focused on the collection of CBUs would not necessarily be required.
Success criteria for minority donor programs A necessary pre-condition for the success of a minority donor program is the number of recruited stem cell donors of the addressed ethnic group. As differences in availability rates between donors of various ethnic groups have been described, 3, 4 there should be a special focus on donor availability. Young male donors are generally preferred by transplant physicians. 9, 10 Therefore, age and gender distributions of recruited minority donors are also of interest.
Recruited minority donors should also add HLA diversity to the donor pool. This goal can be achieved if two pre-conditions are fulfilled: First, the targeted ethnic group should differ sufficiently from the existing donor pool with respect to HLA phenotype frequency distributions. Second, an adequate number of minority donors has to be recruited. This criterion is therefore closely related to the above-mentioned success criterion.
Finally, the number of donations from recruited minority donors is the most relevant criterion. In view of the project goal to improve the chances for patients of the addressed minority group finding matching donors, the number of minority donors donating for patients from this respective group is of special interest. Furthermore, the phenotype frequencies of minority donors who actually donate are relevant. Low frequencies, and especially unique phenotypes, suggest that donations would possibly not have taken place without the actual donors and indicate an especially high impact of the program.
Analyses
Typing results obtained through DNA-based methods were transformed into serological values for analyses regarding haplotype or phenotype frequencies.
Genetic distances between populations were calculated by applying the Cavalli-Sforza and Edwards chord distance. 11 A two-dimensional visualization of calculated distances was obtained through multidimensional scaling by using SPSS.
The Arlequin software package 12 was used to calculate haplotype frequencies 13 and perform tests for HardyWeinberg equilibrium.
14 To avoid a bias through HLA-AB phenotype-dependent DR typing, for example, within the scope of donor searches, we used data sets of donors who were typed for at least the A, B and DR loci at recruitment for these calculations. Analyzed data sets consisted of 9086 (8839) donors of Turkish (German) descent. Haplotype frequency ranks of various data sets were compared using Spearman's rank correlation coefficient r as they did not include tied ranks. For phenotype frequency ranks, Pearson's correlation coefficient between ranks was applied.
Analyses at the allele level were carried out for two samples of 15 845 (16 000) Turkish (German) donors who were typed through sequencing for the A*, B*, C* and DRB1* loci at recruitment. Owing to ambiguous typing combinations over relevant exons, typing did not always lead to allele level results. Such ambiguities occurred in 12.9% (11.7%) of Turkish (German) donors for the DRB1* locus. For allele frequency determinations, the resulting multi-allele codes were resolved to the alleles included proportionally to the occurrence of these alleles in the respective samples. As the ratio of ambiguities was considerably higher for Class I loci, we restrict our allelelevel analyses to the DRB1* locus.
Results
In this section, we have applied the above-mentioned criteria to the case of the Turkish minority in Germany and the minority donor program of the DKMS German Bone Marrow Donor Center focused on Turkish donors.
Potentially accessible minority donors
From the perspective of a German donor center, the first criterion for program initiation (see the Methods section) establishes the ethnic group of Turkish individuals in Germany as natural candidates for a minority donor program as they contribute by far the largest ethnic minority group in Germany with about 2 500 000 individuals. 15 It should be noted that we do not differentiate between various ethnic groups within Turkey since newly recruited donors are asked for their descent based on nationality. This specifically means that within this article, 'donors of Turkish descent' include Kurds and other ethnic groups originating from Turkey.
Improvement of chances to find matching donors As Turks are Caucasians, the identification of Turkish patients through racial information as used by several donor registries is not possible. In addition, it is known that there are factors apart from HLA matching that contribute to the probability of an initiated donor search leading to transplantation. These factors might also depend on the patient's ethnic background. 16 Such difficulties are probably the main reason for the fact that, to date, no quantitative study results confirm reports from German search coordinators regarding lower probabilities of successful donor searches for Turkish patients.
As suggested in the Methods section, we therefore focused our analyses on the number of registered and available donors from the ethnic group addressed along with genetic differences between HLA phenotypes of this group and other ethnic groups with large donor pools.
In Turkey, two registries exist with 32 258 and 2367 donors, respectively. 17, 18 Less than 2000 of these donors are typed for the HLA-DR locus. 18 This fact limits the benefits of these registries for patients in need of a stem cell transplant as it has been shown that donors who are typed only for the HLA-A and -B loci proceed to donation infrequently. 3 Besides, the donor availability rate of the larger Turkish registry is only 12% on the confirmatory typing level. Although it is not obvious to which extent our data that are based on migrants to Germany can be generalized, this result is in good accordance with published analyses regarding the genetic relationship of Turks to other populations. 19 The national registry sizes including CBUs are 22 108 for Greece and 344 061 for Italy. 18 In addition, there are two registries with 108 179 donors in total in Cyprus 18 that should also show a high genetic similarity. Furthermore, there are 1856 (4474) donors of Greek (Italian) origin in the DKMS donor file. Including the Turkish DKMS donors, we roughly estimate that there are about 500 000 registered donors or more in the worldwide donor pool who are of Turkish descent or from closely related populations.
To further investigate HLA differences between Turkish and German DKMS donors, we calculated HLA-ABDR low-resolution haplotype frequencies for both groups. Figure 2 displays the 10 most frequent haplotypes of DKMS donors of Turkish descent, the frequencies and ranks of these haplotypes for DKMS donors of German descent, and the corresponding haplotype ranks for a sample of the Ankara registry TRAN (n ¼ 699). 20 Haplotype frequencies show considerable differences between both groups of DKMS donors by factors up to 9.01 (for the haplotype A11,B52,DR15). When frequency ranks of the 10 haplotypes displayed in Figure 2 are compared between the various samples, the resulting values for Spearman's r are 0.61 (both data sets with Turkish donors), 0.10 (both data sets with DKMS donors) and À0.08 (donors from TRAN and German DKMS donors). Corresponding probabilities are 0.07, 0.76 and 0.81, respectively. Therefore, the null hypothesis (no statistically significant correlation) cannot be rejected even for the two samples of Turkish donors. Apart from the restriction of the analysis to only 10 haplotypes, this fact might also be induced through different regional origins of TRAN donors and Turkish DKMS donors. Figure 3 shows that DKMS donors of Turkish and German descent also differ with respect to intra-population HLA diversity. The cumulated frequencies for the n most 
frequent HLA-ABDR low-resolution haplotypes are lower for Turkish donors and thus show a higher intra-population HLA diversity for this group. For n ¼ 250, for example, the frequencies are 0.61 and 0.69 for Turkish and German donors, respectively. Deviations from Hardy-Weinberg equilibrium are significant for the data set of Turkish DKMS donors for all three loci analyzed (P ¼ 2 Â 10 À4 for HLA-A, Po10 À5 for HLA-B, P ¼ 8 Â 10
À4 for HLA-DR). Although significant deviations from Hardy-Weinberg equilibrium are not unusual for such a large data set of about 9000 donors, the differences to the sample of German donors (P ¼ 0.26 for HLA-A, P ¼ 0.07 for HLA-B, P ¼ 0.99 for HLA-DR) are nevertheless noticeable. As observed heterozygosities are smaller than expected for all three loci in the sample of Turkish donors (for example, h obs ¼ 0.856 vs h exp ¼ 0.878 for HLA-A), this observation could possibly be induced through the Wahlund effect (reduction of heterozygosity as a result of sub-population structure) as several ethnic groups, including Kurds, are summarized under the nationality Turkish in this work.
General access to unrelated allo-SCT for patients from the addressed ethnic group The two countries with the largest Turkish populations are Turkey with about 72 000 000 and Germany with 2 500 000 individuals. Generally, there is access to allo-SCT in Turkey. However, the overall allogeneic transplantation figures and the ratio of unrelated transplants are low compared with many other countries participating in the EBMT activity survey. 21 The results of this survey indicate the considerable influence of economic factors on transplantation figures, especially on the figures for unrelated transplantations. It therefore seems plausible that the low unrelated transplantation figures in Turkey might also be induced by economic factors and not only by a lack of matching unrelated donors. As a consequence, a minority donor program focused on donors of Turkish descent could be of limited use for patients living in Turkey. Owing to the German legal health insurance system, patients of Turkish descent who live in Germany have access to allo-SCT. The same should hold for most Turkish migrants to other Western European countries.
In Germany, only eight allogeneic cord blood transplants were carried out in 2007. 22 In Turkey, there is no frequent use of CBUs for allogeneic transplantation, either. Therefore, a strong focus on the collection of CBUs currently seems not to be necessarily required within the analyzed minority donor program. Owing to the potential efficiency of CBU collection to improve the chances of minority patients finding sufficiently matching donors and the time needed to build up a cord blood inventory of relevant size, such efforts should also not be neglected. However, one has to be aware that the positive effects of such a program will not be fully realized until the general figures regarding cord blood use in Turkey and Germany have increased considerably. Figure 4 . The curve for German donors differs considerably from an earlier published version for the total DKMS file 10 for two reasons in the main. First, there was ongoing donor recruitment with a specific focus on young donors between these two snapshots. Second, at DKMS, the systematic collection of information on the ethnic descent of new donors started in 2002. Donors without such information were not included in the analysis. Therefore, the curves in Figure 4 are based on a subset of donors who were mainly recruited in 2002 or later. In summary, it can be stated that demographic characteristics (age and gender distributions) are more favorable for donors of Turkish descent than for German donors.
Recruited donors and availability rates
Low minority donor availability through high withdrawal rates is an issue within the analyzed project. We succeeded in reducing the withdrawal rate of donors of Turkish descent on the confirmatory typing level from 37.4% in 2004 to 20.4% in 2007. The possible factors contributing to this improvement are optimized information at recruitment and native speaker support at recruitment and during the various steps of the search process, especially on the confirmatory typing level. From our experience, the involvement of donor center staff from the ethnic group being addressed improves communication and is essential for the project's success. It has, however, to be noticed that the withdrawal rate of donors of Turkish descent on the confirmatory typing level is still high compared with the corresponding rate of all other donors in the DKMS file (4.2%). The corresponding rates of Polish, Italian, Russian and German donors are 9.6, 10.6, 24.0 and 3.7%, respectively. Apart from Turkish donors, Polish, Italian and Russian donors make up the largest minority groups in the DKMS file.
HLA phenotypes of recruited donors
Seventeen of the 20 most frequent HLA-ABDR lowresolution phenotypes of Turkish DKMS donors are not among the 1000 most frequent phenotypes of non-Turkish DKMS donors (Table 1) . This fact and the rank correlation coefficient between these groups of 0.14 for the 20 haplotypes displayed in Table 1 underline the genetic difference between Turkish donors and the rest of the donor file. Nevertheless, there are more non-Turkish than Turkish donors in the file for 18 of these 20 phenotypes. This result is mainly because of the much higher number of non-Turkish donors in the file under consideration. Our results suggest that patients with common Turkish HLA phenotypes may also benefit from a large German stem cell donor file without specific minority recruiting efforts.
On the other hand, the fraction of donors with unique phenotypes in the file is much higher for Turkish (31.0%) than for non-Turkish (16.6%) donors.
High-resolution HLA matching has been shown to be relevant for optimal donor selection. 24 We therefore also analyzed HLA-DRB1* allele frequencies for Turkish and German donors. The results are shown in Table 2 . It shows that a higher intra-population HLA diversity for Turkish donors compared with German donors can also be observed on the allele level: Apart from three allele groups without any intra-group variability in our samples (DRB1*07, DRB1*09 and DRB1*10), the fractions of the most frequent alleles are significantly lower for the sample of Turkish donors (P ¼ 0.04 for DRB1*03, Po10
À4 for all other allele groups).
For 3 of 10 allele groups with intra-group variability, the most frequent alleles differ between the samples of German and Turkish donors (DRB1*04, DRB1*08 and DRB1*11). Similar to the most frequent HLA-ABDR low-resolution phenotypes, the most frequent DRB1* alleles of Turkish donors occur, in absolute figures, more often in German donors in the DKMS donor file. Among the 30 most frequent Turkish DRB1* alleles, the highest frequency ratio between Turkish and German donors is 10.04 for DRB1*1404. As the ratio between German and Turkish The two phenotypes that are at least as often available among donors of Turkish descent as among other donors are marked with an asterisk. 
Discussion
In this work, we identify criteria for initiation and measurement of success of minority donor programs. The relevant questions in this context are: Should a minority donor program for a specific ethnic group be initiated? Can an existing program be regarded as successful? If not, which factors limit success and should primarily be addressed?
The criteria presented will often provide guidance in decision-making processes, rather than leading to definite answers. One important tool that could further improve decision-making in this situation is cost-benefit analysis. However, an exhaustive quantitative cost-benefit analysis of donor recruitment has not yet been accomplished for several reasons. 4, 10 The closely related question of optimal donor registry size is therefore still unresolved. Apart from these general difficulties, there are additional problems in our minority program setting that have to be taken into account when analyzing the program benefits: First, it is difficult to assess to which extent patients in Turkey benefit from ongoing donor recruitment, as the EBMT activity survey suggests that non-HLA barriers to transplantation play an important role for these patients. 21 Second, it is not obvious how program benefits should be assessed generally. It is the primary goal of the project to increase the chances for patients of Turkish descent to find matching stem cell donors. From this perspective, a stem cell donation of a Turkish donor for a patient from another ethnic group would create no benefit. Obviously, this approach is not useful. Third, there is a chance, maybe a small one, that projects such as the one described in this article can influence the relationship of social groups with different ethnic and cultural backgrounds in a positive way. Such effects would be difficult to prove and even more difficult to quantify.
Even without a quantitative cost-benefit analysis, there is evidence available from our criteria that the program is of limited use for patients with HLA phenotypes that are common in the Turkish population. First, there are, roughly estimated, about 500 000 or more donors worldwide who are of Turkish descent or from genetically closely related populations. Second, our analyses show that the most common Turkish HLA-ABDR phenotypes in the DKMS donor file are shared by more non-Turkish than Turkish donors. This result is induced by the ratio between non-Turkish (mostly German) and Turkish donors in the DKMS file and the genetic relation between these two groups. Given the current ratio of E40, Germans and Turks are so closely related that the described effect occurs.
However, our results suggest the existence of substantial program benefits for Turkish and non-Turkish patients with rare HLA phenotypes. The fraction of Turkish donors with unique HLA-ABDR low-resolution phenotypes in the DKMS file is considerably higher than those of the other donors in the same file. This holds for analyses of the total donor file and of the donors who actually donated. These differences are partly due to the fact that Turkish donors make up only a small part of the donor file under consideration. On the other hand, it should be noted that this small part of the file includes more donors of Turkish descent than do the registries in Turkey. In addition, the high proportion of Turkish donors with unique phenotypes also results from the intrapopulation HLA diversity that is higher for the Turkish than the German population ( Figure 3) . The higher HLA diversity that is present on the allele level also indicates a special need for donor recruitment in the Turkish population.
It is disappointing that only one Turkish DKMS donor has donated for a patient in Turkey to date. We assume that this result is partly caused by non-HLA barriers to transplantation in Turkey. As a consequence, however, there is considerable potential for additional program benefits in the future.
DKMS plans to continue with the program described. Although they have improved considerably, the high withdrawal rates of donors of Turkish descent are still a major shortcoming of the project. To improve on this aspect, we are planning a study to compare the attitudes of donors of German and Turkish descent to optimize our communication measures toward minority donors at recruitment and through the various steps of the donor search process.
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